Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock

Current Vascular Pharmacology

Volumn 3, Issue 3, 2005, Pages 293-299

  Evgenov, Oleg V ^a   Liaudet, Lucas ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Circulatory shock; Endothelial dysfunction; Hemorrhage; Inflammation; Myocardial depression; Peroxynitrite; Poly(adenosine 5 diphosphate ribose) polymerase 1; Sepsis

Indexed keywords

3 AMINOBENZAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INO 1001; MITOGEN ACTIVATED PROTEIN KINASE; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

APOPTOSIS; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DNA STRAND BREAKAGE; ELECTRON TRANSPORT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; GENE EXPRESSION; GLYCOLYSIS; HEMORRHAGIC SHOCK; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; REVIEW; SEPTIC SHOCK;

ANIMALS; ANOXIA; CARDIOVASCULAR DISEASES; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INFLAMMATION MEDIATORS; POLY(ADP-RIBOSE) POLYMERASES; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SEPSIS; SHOCK, HEMORRHAGIC; SIGNAL TRANSDUCTION;

EID: 21644454451     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570161054368580     Document Type: Review

References (99)

1. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B; CUB-Rea Network. Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003; 168: 165-72.
2. Eastridge BJ, Starr A, Minei JP, O'Keefe GE, Scalea TM. The importance of fracture pattern in guiding therapeutic decision-making in patients with hemorrhagic shock and pelvic ring disruptions. J Trauma 2002; 53: 446-51.
3. Shall S, de Murcia G. Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat Res 2000; 460: 1-15.
4. Simbulan-Rosenthal CM, Ly DH, Rosenthal DS, Konopka G, Luo P, Wang ZQ, et al. Misregulation of gene expression in primary fibroblasts lacking poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A 2000; 97: 11274-9.
5. Ame JC, Rolli V, Schreiber V, Niedergang C, Apiou F, Decker P, et al. PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem 1999; 274: 17860-8.
6. Kickhoefer VA, Siva AC, Kedersha NL, Inman EM, Ruland C, Streuli M, et al. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol 1999; 146: 917-28.
7. Smith S, Giriat I, Schmitt A, de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998; 282: 1484-7.
8. de Murcia G, Menissier de Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem Sci 1994; 19: 172-6.
9. Lautier D, Lagueux 3, Thibodeau J, Menard L, Poirier GG. Molecular and biochemical features of poly (ADP-ribose) metabolism. Mol Cell Biochem 1993; 122:171-93.
10. Althaus FR, Kleczkowska HE, Malanga M, Muntener CR, Pleschke JM, Ebner M, et al. Poly ADP-ribosylation: a DNA break signal mechanism. Mol Cell Biochem 1999; 193: 5-11.
11. D'Amours D, Desnoyers S, D'Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 1999; 342: 249-68.
12. Davidovic L, Vodenicharov M, Affar EB, Poirier GG. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp Cell Res 2001; 268: 7-13.
13. Szabo C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 1998; 19: 287-98.
14. Szabo C. Role of poly(ADP-ribose) synthetase activation in the suppression of cellular energetics in response to nitric oxide and peroxynitrite. Biochem Soc Trans 1997; 25: 919-24.
15. Szabo C. DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic Biol Med 1996; 21: 855-69.
16. Berger SJ, Sudar DC, Berger NA. Metabolic consequences of DNA damage: DNA damage induces alterations in glucose metabolism by activation of poly(ADP-ribose) polymerase. Biochem Biophys Res Commun 1986; 134: 227-32.
17. Schraufstatter IU, Hinshaw DB, Hyslop PA, Spragg RG, Cochrane CG. Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J Clin Invest 1986; 77: 1312-20.
18. Thies RL, Autor AP. Reactive oxygen injury to cultured pulmonary artery endothelial cells: mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance. Arch Biochem Biophys 1991; 286: 353-63.
19. Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999; 96: 13978-82.
20. Liaudet L. Poly(adenosine 5′-diphosphate) ribose polymerase activation as a cause of metabolic dysfunction in critical illness. Curr Opin Clin Nutr Metab Care 2002; 5: 175-84.
21. Virag L, Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54: 375-429.
22. Otani H, Tanaka H, Inoue T, Umemoto M, Omoto K, Tanaka K, et al. In vitro study on contribution of oxidative metabolism of isolated rabbit heart mitochondria to myocardial reperfusion injury. Circ Res 1984; 55: 168-75.
23. Nohl H. Generation of superoxide radicals as byproduct of cellular respiration. Ann Biol Clin 1994; 52: 199-204.
24. Tan S, Yokoyama Y, Dickens E, Cash TG, Freeman BA, Parks DA. Xanthine oxidase activity in the circulation of rats following hemorrhagic shock. Free Radic Biol Med 1993; 15: 407-14.
25. Engerson TD, McKelvey TG, Rhyne DB, Boggio EB, Snyder SJ, Jones HP. Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues. J Clin Invest 1987; 79: 1564-70.
26. Brandes RP, Koddenberg G, Gwinner W, Kim D, Kruse HJ, Busse R, et al. Role of increased production of superoxide anions by NAD(P)H oxidase and xanthine oxidase in prolonged endotoxemia. Hypertension 1999; 33: 1243-9.
27. Ozaki M, Deshpande SS, Angkeow P, Bellan J, Lowenstein CJ, Dinauer MC, et al. Inhibition of the Rac1 GTPase protects against nonlethal ischemia/reperfusion-induced necrosis and apoptosis in vivo. FASEB J 2000; 14: 418-29.
28. Liaudet L, Soriano FG, Szabo C. Biology of nitric oxide signaling. Crit Care Med 2000; 28(Suppl): N37-52.
29. Liaudet L, Yang Z, Al-Affar EB, Szabo C. Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase. Mol Med 2001; 7: 406-17.
30. Liaudet L, Soriano FG, Szabo E, Virag L, Mabley JG, Salzman AL, et al. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase. Proc Natl Acad Sci USA 2000; 97: 10203-8.
31. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151: 1250-4.
32. Szabo C, Salzman AL, Ischiropoulos H. Peroxynitrite-mediated oxidation of dihydrorhodamine 123 occurs in early stages of endotoxic and hemorrhagic shock and ischemia-reperfusion injury. FEBS Lett 1995; 372: 229-32.
33. Kiefmann R, Heckel K, Doerger M, Schenkat S, Kupatt C, Stoeckelhuber M, et al. Role of PARP on iNOS pathway during endotoxin-induced acute lung injury. Intensive Care Med 2004; 30: 1421-31.
34. Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite. Methods Enzymol 1994; 233: 229-40.
35. Koppenol WH. The basic chemistry of nitrogen monoxide and peroxynitrite. Free Radic Biol Med 1998; 25: 385-91.
36. Szabo C, Ohshima H. DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide 1997; 1: 373-85.
37. Szabo C, Saunders C, O'Connor M, Salzman AL. Peroxynitrite causes energy depletion and increases permeability via activation of poly (ADP-ribose) synthetase in pulmonary epithelial cells. Am J Respir Cell Mol Biol 1997; 16: 105-9.
38. Kennedy M, Denenberg AG, Szabo C, Salzman AL. Poly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology 1998; 114: 510-8.
39. Szabo C, Zingarelli B, Salzman AL. Role of poly-ADP ribosyl-transferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res 1996; 78: 1051-63.
40. Szabo C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 1997; 100: 723-35.
41. Szabo C, Virag L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, et al. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 1998; 95: 3867-72.
42. Szabo C, Zingarelli B, O'Connor M, Salzman AL. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci USA 1996; 93: 1753-8.
43. Zingarelli B, O'Connor M, Wong H, Salzman AL, Szabo C. Peroxynitrite-mediated DNA strand breakage activates polyadenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol 1996; 156: 350-8.
44. Astiz M, Rackow EC, Weil MH, Schumer W. Early impairment of oxidative metabolism and energy production in severe sepsis. Circ Shock 1988; 26: 311-20.
45. Van Lambalgen AA, van Kraats AA, Mulder MF, Teerlink T, van den Bos GC. High-energy phosphates in heart, liver, kidney, and skeletal muscle of endotoxemic rats. Am J Physiol 1994; 266: H1581-7.
46. Revelly JP, Liaudet L, Frascarolo P, Joseph JM, Martinet O, Markert M. Effects of norepinephrine on the distribution of intestinal blood flow and tissue adenosine triphosphate content in endotoxic shock. Crit Care Med 2000; 28: 2500-6.
47. Fink MP. Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 2001; 17: 219-37.
48. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA, Cochrane CG. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci USA 1986; 83: 4908-12.
49. Hillyard D, Rechsteiner M, Manlapaz-Ramos P, Imperial JS, Cruz LJ, Olivera BM. The pyridine nucleotide cycle. Studies in Escherichia coli and the human cell line D98/AH2. J Biol Chem 1981; 256: 8491-7.
50. Carson DA, Seto S, Wasson DB, Carrera CJ. DNA strand breaks, NAD metabolism, and programmed cell death. Exp Cell Res 1986; 164: 273-81.
51. Pilkis SJ, Granner DK. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Ann Rev Physiol 1992; 54: 885-909.
52. Patel MS, Roche TE. Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J 1990; 4: 3224-33.
53. Remington SJ. Structure and mechanism of citrate synthase. Curr Top Cell Regul 1992; 33: 209-29.
54. Srere PA. The molecular physiology of citrate. Curr Top Cell Regul 1992; 33:261-75.
55. Stryer L. Oxydative phosphorylation. In: Stryer L Ed, Biochemistry. New York, Freeman WH 1995; 529-58.
56. Bernofsky C. Physiology aspects of pyridine nucleotide regulation in mammals. Mol Cell Biochem 1980; 33: 135-43.
57. Virag L, Salzman AL, Szabo C. Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 1998; 161: 3753-9.
58. 2 cytotoxicity by inhibiting poly(ADP-ribose) polymerase. Biochem Biophys Res Commun 2000; 278: 590-8.
59. Andreoli SP. Mechanisms of endothelial cell ATP depletion after oxidant injury. Pediatr Res 1989; 25: 97-101.
60. Gilad E, Zingarelli B, Salzman AL, Szabo C. Protection by inhibition of poly(ADP-ribose) synthetase against oxidant injury in cardiac myoblasts in vitro. J Mol Cell Cardiol 1997; 29: 2585-97.
61. Bowes J, Piper J, Thiemermann C. Inhibitors of the activity of poly(ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts. Br J Pharmacol 1998; 124: 1760-6.
62. 2 but not apoptosis. Gastroenterology 1995; 109: 472-82.
63. Hudak BB, Tufariello J, Sokolowski J, Maloney C, Holm BA. Inhibition of poly(ADP-ribose) polymerase preserves surfactant synthesis after hydrogen peroxide exposure. Am J Physiol 1995; 269: L59-64.
64. Liaudet L, Soriano FG, Szabo C. Poly(ADP-ribose) synthetase as a novel therapeutic target for circulatory shock. In: Vincent JL Ed, Yearbook of intensive care and emergency medicine. Heidelberg, Springer Verlag 2001; 78-89.
65. Pulido EJ, Shames BD, Selzman CH, Barton HA, Banerjee A, Bensard DD, et al. Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation. Am J Physiol 1999; 277: L769-76.
66. Watts JA, Grattan RM 2nd, Whitlow BS, Kline JA. Activation of poly(ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation. Am J Physiol Gastrointest Liver Physiol 2001; 281: G498-506.
67. Szabo A, Hake P, Salzman AL, Szabo C. 3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock. Shock 1998; 10: 347-53.
68. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 1995; 3: 2-32.
69. Chabot F, Mitchell JA, Quinlan GJ, Evans TW. Characterization of the vasodilator properties of peroxynitrite on rat pulmonary artery: role of poly (adenosine 5′-diphosphoribose) synthase. Br J Pharmacol 1997; 121: 485-90.
70. Szabo C, Salzman AL, Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett. 1995; 363: 235-8.
71. Zingarelli B, Day BJ, Crapo JD, Salzman AL, Szabo C. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 1997; 120: 259-67.
72. Jagtap P, Soriano FG, Virag L, Liaudet L, Mabley J, Szabo E, et al. Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med 2002; 30: 1071-82.
73. Zingarelli B, Salzman AL, Szabo C. Protective effects of nicotinamide against nitric oxide-mediated delayed vascular failure in endotoxic shock: potential involvement of polyADP ribosyl synthetase. Shock 1996; 5: 258-64.
74. Soriano FG, Liaudet L, Szabo E, Virag L, Mabley JG, Pacher P, et al. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1 deficient mice. Shock 2002; 17: 286-92.
75. Kuhnle S, Nicotera P, Wendel A, Leist M. Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly(ADP-ribose) polymerase-deficient mice. Biochem Biophys Res Commun 1999; 263: 433-8.
76. Pacher P, Cziraki A, Mabley JG, Liaudet L, Papp L, Szabo C. Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem Pharmacol 2002; 64: 1785-91.
77. Goldfarb RD, Marton A, Szabo E, Virag L, Salzman AL, Glock D, et al. Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med 2002; 30: 974-80.
78. St John J, Barbee RW, Sonin N, Clemens MG, Watts JA. Inhibition of poly(ADP-ribose) synthetase improves vascular contractile responses following trauma-hemorrhage and resuscitation. Shock 1999; 12: 188-95.
79. McDonald MC, Filipe HM, Thiemermann C. Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock. Br J Pharmacol 1999; 128: 1339-45.
80. McDonald MC, Mota-Filipe H, Wright JA, Abdelrahman M, Threadgill MD, Thompson AS, et al. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polyrnerase on the organ injury and dysfunction caused by haemorrhagic shock. Br J Pharmacol 2000; 130: 843-50.
81. Spragg RG, Hinshaw DB, Hyslop PA, Schraufstatter IU, Cochrane CG. Alterations in adenosine triphosphate and energy charge in cultured endothelial and P388D1 cells after oxidant injury. J Clin Invest 1985; 76: 1471-6.
82. Junod AF, Jornot L, Petersen H. Differential effects of hyperoxia and hydrogen peroxide on DNA damage, polyadenosine diphosphate-ribose polymerase activity, and nicotinamide adenine dinucleotide and adenosine triphosphate contents in cultured endothelial cells and fibroblasts. J Cell Physiol 1989; 140: 177-85.
83. Villa LM, Salas E, Darley-Usmar VM, Radomski MW, Moncada S. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci USA 1994; 91: 12383-7.
84. Szabo A, Salzman AL, Szabo C. Poly (ADP-ribose) synthetase activation mediates pulmonary microvascular and intestinal mucosal dysfunction in endotoxin shock. Life Sci 1998; 63: 2133-9.
85. Garcia Soriano F, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 2001; 7: 108-13.
86. Ivanyi Z, Hauser B, Pittner A, Asfar P, Vassilev D, Nalos M, et al. Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia. Shock 2003; 19: 415-21.
87. Abraham E. NF-κB activation. Crit Care Med 2000; 28(Suppl): N100-4.
88. Hassa PO, Hottiger MO. The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders. Cell Mol Life Sci 2002; 59: 1534-53.
89. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, et al. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 1999; 18: 4446-54.
90. Kameoka M, Ota K, Tetsuka T, Tanaka Y, Itaya A, Okamoto T, et al. Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase. Biochem J 2000; 346: 641-9.
91. Veres B, Radnai B, Gallyas F Jr, Varbiro G, Berente Z, Osz E, et al. Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. J Pharmacol Exp Ther 2004; 310: 247-55.
92. Liaudet L, Pacher P, Mabley JG, Virag L, Soriano FG, Hasko G, et al. Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation. Am J Respir Crit Care Med 2002; 165: 372-7.
93. Murakami K, Enkhbaatar P, Shimoda K, Cox RA, Burke AS, Hawkins HK, et al. Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis. Shock 2004; 21: 126-33.
94. Petrilli V, Herceg Z, Hassa PO, Patel NS, Di Paola R, Cortes U, et al. Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice. J Clin Invest 2004; 114: 1072-81.
95. 2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J Biol Chem 1995; 270: 18966-74.
96. Nie J, Sakamoto S, Song D, Qu Z, Ota K, Taniguchi T. Interaction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase. FEBS Lett 1998; 424: 27-32.
97. Kannan P, Yu Y, Wankhade S, Tainsky MA. PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucleic Acids Res 1999; 27: 866-74.
98. Butler AJ, Ordahl CP. Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol Cell Biol 1999; 19: 296-306.
99. Oei SL, Shi Y. Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage. Biochem Biophys Res Commun 2001; 285: 27-31.